GEODE CAPITAL MANAGEMENT, LLC - ACASTI PHARMA INC ownership

ACASTI PHARMA INC's ticker is ACST and the CUSIP is 00430K402. A total of 33 filers reported holding ACASTI PHARMA INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of ACASTI PHARMA INC
ValueSharesWeighting
Q2 2021$82,000
-21.2%
146,784
-15.9%
0.00%
Q1 2021$104,000
+85.7%
174,5930.0%0.00%
Q4 2020$56,000
+366.7%
174,593
+185.1%
0.00%
Q3 2020$12,000
-57.1%
61,2350.0%0.00%
Q2 2020$28,000
+21.7%
61,2350.0%0.00%
Q1 2020$23,000
-92.3%
61,235
-50.0%
0.00%
Q4 2019$300,000
+160.9%
122,470
+100.0%
0.00%
Q3 2019$115,000
+69.1%
61,2350.0%0.00%
Q2 2019$68,000
+38.8%
61,235
+25.8%
0.00%
Q1 2019$49,000
-38.8%
48,665
-50.0%
0.00%
Q4 2018$80,00097,3300.00%
Other shareholders
ACASTI PHARMA INC shareholders Q4 2019
NameSharesValueWeighting ↓
Perceptive Advisors 236,559$414,0000.03%
INTACT INVESTMENT MANAGEMENT INC. 89,490$206,0000.01%
Virtu KCG Holdings LLC 29,187$52,0000.00%
TORONTO DOMINION BANK 25$00.00%
BANK OF MONTREAL /CAN/ 177,389$317,0000.00%
Tower Research Capital LLC (TRC) 600$1,0000.00%
Renaissance Technologies 35,400$63,0000.00%
ROYAL BANK OF CANADA 75$00.00%
UBS Group AG 1,061$2,0000.00%
View complete list of ACASTI PHARMA INC shareholders